A fused gene of nucleoprotein (NIP) and herpes simplex virus genes (VP22) induces highly protective immunity against different subtypes of influenza virus

被引:50
作者
Saha, Sukumar [1 ]
Yoshida, Shinsuke [1 ]
Ohba, Kenji [1 ]
Matsui, Kiyohiko [1 ]
Matsuda, Tomoko [1 ]
Takeshita, Fumihiko [1 ]
Umeda, Kazunori [1 ]
Tamura, Yuichi [1 ]
Okuda, Kentaro [3 ]
Klinman, Dennis [2 ]
Xin, Ke-Qin [1 ]
Okuda, Kenji [1 ]
机构
[1] Yokohama City Univ, Grad Sch Med, Dept Mol Biodef Res, Kanazawa Ku, 3-9 Fukuura, Yokohama, Kanagawa 2360004, Japan
[2] US FDA, CBER, Bethesda, MD 20892 USA
[3] Kyushu Univ, Fac Med Sci, Dept Oral Hlth Technol & Epidemiol, Fukuoka 81285822, Japan
关键词
influenza nucleoprotein (NP); herpes simplex virus gene protein 22 (VP22); DNA vaccine; A/PR/8/34; HSV-1; CD8(+) cells; CD4(+) cells; intercellular spreading;
D O I
10.1016/j.virol.2006.04.015
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
We evaluated the immunogenicity and protective activity of plasmid DNA vaccines encoding the influenza virus NP gene (pNP) alone or in combination with the herpes simplex virus type 1 protein 22 gene (pVP22). Optimal immune responses were observed in BALB/c mice immunized with the combination of pVP22 plus pNP, as assessed by enzyme-linked immunosorbent assay (ELISA), enzyme-linked immunospot (ELISPOT) and intracellular cytokine staining (ICCS). These mice also showed maximal resistance following challenge with the A/PR/8/34 (H1N1) and A/Udron/72 (H3N2) strains of influenza virus. The susceptibility of immunized mice to virus infection was significantly increased following depletion of either CD4(+) or CD8(+) T cells. These results indicate that a plasmid DNA vaccine encoding pVP22 plus NP induces a high level of cross-protective immunity against influenza virus subtypes. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:48 / 57
页数:10
相关论文
共 43 条
[1]   Intracellular localization of proteasomal degradation of a viral antigen [J].
Antón, LC ;
Schubert, U ;
Bacík, I ;
Princiotta, MF ;
Wearsch, PA ;
Gibbs, J ;
Day, PM ;
Realini, C ;
Rechsteiner, MC ;
Bennink, JR ;
Yewdell, JW .
JOURNAL OF CELL BIOLOGY, 1999, 146 (01) :113-124
[2]   Electroporation improves the efficacy of DNA vaccines in large animals [J].
Babiuk, S ;
Baca-Estrada, ME ;
Foldvari, M ;
Storms, M ;
Rabussay, D ;
Widera, G ;
Babiuk, LA .
VACCINE, 2002, 20 (27-28) :3399-3408
[3]   Influenza virus nucleoprotein interacts with influenza virus polymerase proteins [J].
Biswas, SK ;
Boutz, PL ;
Nayak, DP .
JOURNAL OF VIROLOGY, 1998, 72 (07) :5493-5501
[4]   ENHANCED RECOGNITION OF A MODIFIED PEPTIDE ANTIGEN BY CYTOTOXIC-T CELLS SPECIFIC FOR INFLUENZA NUCLEOPROTEIN [J].
BODMER, HC ;
PEMBERTON, RM ;
ROTHBARD, JB ;
ASKONAS, BA .
CELL, 1988, 52 (02) :253-258
[5]   DNA immunization of newborn mice with a plasmid-expressing nucleoprotein of influenza virus [J].
Bot, A ;
Bot, S ;
GarciaSastre, A ;
Bona, C .
VIRAL IMMUNOLOGY, 1996, 9 (04) :207-210
[6]   Particle assembly incorporating a VP22-BH3 fusion protein, facilitating intracellular delivery, regulated release, and apoptosis [J].
Brewis, ND ;
Phelan, A ;
Normand, N ;
Choolun, E ;
O'Hare, P .
MOLECULAR THERAPY, 2003, 7 (02) :262-270
[7]   Several protein regions contribute to determine the nuclear and cytoplasmic localization of the influenza A virus nucleoprotein [J].
Bullido, R ;
Gómez-Puertas, P ;
Albo, C ;
Portela, A .
JOURNAL OF GENERAL VIROLOGY, 2000, 81 :135-142
[8]   Protection and antibody responses in different strains of mouse immunized with plasmid DNAs encoding influenza virus haemagglutinin, neuraminidase and nucleoprotein [J].
Chen, Z ;
Yoshikawa, T ;
Kadowaki, S ;
Hagiwara, Y ;
Matsuo, K ;
Asanuma, H ;
Aizawa, C ;
Kurata, T ;
Tamura, S .
JOURNAL OF GENERAL VIROLOGY, 1999, 80 :2559-2564
[9]   Non-lethal viral challenge of influenza haemagglutinin and nucleoprotein DNA vaccinated mice results in reduced viral replication [J].
Cox, RJ ;
Mykkeltvedt, E ;
Robertson, J ;
Haaheim, LR .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2002, 55 (01) :14-23
[10]  
DIALYNAS DP, 1983, J IMMUNOL, V131, P2445